Trinity Biotech Files July 2024 Report (6-K)
Ticker: TRIB · Form: 6-K · Filed: Jul 11, 2024 · CIK: 888721
| Field | Detail |
|---|---|
| Company | Trinity Biotech PLC (TRIB) |
| Form Type | 6-K |
| Filed Date | Jul 11, 2024 |
| Risk Level | low |
| Pages | 1 |
| Reading Time | 1 min |
| Sentiment | neutral |
Sentiment: neutral
Topics: 6-K, foreign-private-issuer, regulatory-filing
TL;DR
Trinity Biotech dropped its July 6-K, standard foreign private issuer update.
AI Summary
Trinity Biotech plc filed a Form 6-K on July 11, 2024, to report its activities for the month of July 2024. The company, incorporated in Ireland, is a foreign private issuer and is submitting this report under Rule 13a-16 or 15d-16 of the Securities Exchange Act of 1934. Trinity Biotech is primarily involved in the field of in vitro and in vivo diagnostic substances.
Why It Matters
This filing provides routine updates for investors and regulators regarding Trinity Biotech's ongoing operations and compliance as a foreign private issuer.
Risk Assessment
Risk Level: low — This filing is a routine report for a foreign private issuer and does not contain specific financial or operational disclosures that would indicate elevated risk.
Key Players & Entities
- TRINITY BIOTECH PLC (company) — Registrant
- 0001178913-24-002176 (accession_number) — Filing identifier
- July 2024 (date) — Reporting period
- 2835 (sic_code) — Standard Industrial Classification for diagnostic substances
FAQ
What is the purpose of this Form 6-K filing?
The Form 6-K is a report of a foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934, for the month of July 2024.
What is Trinity Biotech PLC's primary business sector?
Trinity Biotech PLC operates in the 'IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES' sector, classified under SIC code 2835.
Where is Trinity Biotech PLC's principal executive office located?
The principal executive office of Trinity Biotech PLC is located at IDA Business Park, Bray, County Wicklow, Ireland.
Is Trinity Biotech PLC filing its annual report on Form 20-F or Form 40-F?
Trinity Biotech PLC indicates it files annual reports under cover of Form 20-F.
What is the filing date and accession number for this report?
This report was filed on July 11, 2024, with the accession number 0001178913-24-002176.
Filing Stats: 366 words · 1 min read · ~1 pages · Grade level 11.4 · Accepted 2024-07-11 06:55:50
Filing Documents
- zk2431659.htm (6-K) — 14KB
- exhibit_99-1.htm (EX-99.1) — 11KB
- image1.jpg (GRAPHIC) — 90KB
- 0001178913-24-002176.txt ( ) — 150KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. TRINITY BIOTECH PLC Trinity Biotech plc (Registrant) By: /s/ Des Fitzgerald Des Fitzgerald Interim Chief Financial Officer Date: July 11, 2024